Literature DB >> 8068394

Monitoring anticoagulant control in general practice: comparison of management in areas with and without access to hospital anticoagulant.

J P Pell1, J Alcock.   

Abstract

BACKGROUND: Hospital anticoagulant clinics are available only in some areas. There is little information on the contribution of general practitioners to oral anticoagulant monitoring, and whether their management varies with access to hospital clinics. AIM: A study was undertaken to compare general practice management of anticoagulant therapy in two health boards with contrasting access to hospital clinics.
METHOD: A postal questionnaire was sent to the senior partners in all 198 practices in Lothian and Fife, Scotland.
RESULTS: Lack of access to hospital clinics in Lothian health board resulted in more practices reporting taking sole responsibility for anticoagulant control than in Fife where there was access (P < 0.001). However, there was no significant difference in management policies. Overall, 93% of practices used a protocol for thrombotest target ranges, but 75% had no policy on review frequency and only 2% assessed complication or failure rates. Reduced access to hospital clinics was associated with a decreased likelihood of favouring hospital involvement. Sole responsibility for anticoagulant management was undertaken by 56% of general practices, although only 21% of doctors viewed this as ideal. Most general practitioners felt that they should monitor patients on anticoagulant therapy but should refer to hospital those with problematic control.
CONCLUSION: Access to hospital clinics affected the degree of involvement of general practitioners in oral anticoagulant monitoring, but did not considerably alter their management practice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8068394      PMCID: PMC1238952     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  7 in total

1.  Arterial embolism in thyrotoxicosis with atrial fibrillation.

Authors:  J S Staffurth; M C Gibberd; S N Fui
Journal:  Br Med J       Date:  1977-09-10

Review 2.  Current status of antithrombotic therapy in cardiovascular disease.

Authors:  P H Rogers; S Sherry
Journal:  Prog Cardiovasc Dis       Date:  1976 Nov-Dec       Impact factor: 8.194

3.  Therapeutic control of anticoagulant treatment.

Authors:  B M Duxbury
Journal:  Br Med J (Clin Res Ed)       Date:  1982-03-06

4.  Anticoagulants for heart disease.

Authors:  A D Malcolm
Journal:  Br J Hosp Med       Date:  1980-06

5.  Computer control of anticoagulant dose for therapeutic management.

Authors:  P J Ryan; M Gilbert; P E Rose
Journal:  BMJ       Date:  1989-11-11

6.  Comparison of anticoagulant control among patients attending general practice and a hospital anticoagulant clinic.

Authors:  J P Pell; B McIver; P Stuart; D N Malone; J Alcock
Journal:  Br J Gen Pract       Date:  1993-04       Impact factor: 5.386

7.  Long-term oral anticoagulant therapy in elderly patients.

Authors:  L S Wickramasinghe; S K Basu; S K Bansal
Journal:  Age Ageing       Date:  1988-11       Impact factor: 10.668

  7 in total
  4 in total

1.  Recommendations for patients undertaking self management of oral anticoagulation.

Authors:  D A Fitzmaurice; S J Machin
Journal:  BMJ       Date:  2001-10-27

2.  Where should oral anticoagulation monitoring take place?

Authors:  F D Hobbs; D A Fitzmaurice
Journal:  Br J Gen Pract       Date:  1997-08       Impact factor: 5.386

3.  Does the Birmingham model of oral anticoagulation management in primary care work outside trial conditions?

Authors:  D A Fitzmaurice; E T Murray; K M Gee; T F Allan
Journal:  Br J Gen Pract       Date:  2001-10       Impact factor: 5.386

4.  Legal and professional implications of shared care: a case study in oral anticoagulation stroke prevention therapy.

Authors:  Jacqueline A Nicholls; Henry W W Potts; Bridget Coleman; David L Patterson
Journal:  BMC Health Serv Res       Date:  2015-03-10       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.